Market Tracker

11/21 6:05pm ET

Immunomedics Inc (NASDAQ:IMMU)

3.72
Data as of Nov 21
 -0.025 / -0.67%
Today’s Change
3.04
Today|||52-Week Range
6.17
-19.13%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close3.75
Today’s open3.80
Day’s range3.67 - 3.80
Volume368,955
Average volume (3 months)695,315
Market cap$346.5M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-15.08%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book8.80

Competitors

 Today’s
change
Today’s
% change
LMNSLumenis Ltd-0.07-0.67%
CLDNCelladon Corp0.000.00%
ARDXArdelyx Inc+0.64+2.89%
IVCInvacare Corp-0.21-1.35%
Data as of 4:02pm ET, 11/21/2014

Financials

Next reporting dateFebruary 3, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts